Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Journal:
Nature Medicine
Published:
Affiliations:
23
Authors:
23
Institutions Authors Share
Novo Nordisk, Denmark
7.000000
0.30
Hospital das Clínicas da FMUSP, Brazil
1.000000
0.04
The University of Edinburgh, United Kingdom (UK)
1.000000
0.04
UCL, United Kingdom (UK)
1.000000
0.04
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM), United States of America (USA)
1.000000
0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.04
Brigham and Women's Hospital (BWH), United States of America (USA)
1.000000
0.04
Monash University, Australia
1.000000
0.04
University Hospital of Pisa, UNIPI, Italy
1.000000
0.04
Virginia Commonwealth University (VCU), United States of America (USA)
1.000000
0.04
Pennington Biomedical Research Center (PBRC), LSU, United States of America (USA)
1.000000
0.04
University of Washington (UW), United States of America (USA)
1.000000
0.04
Northwestern University (NU), United States of America (USA)
1.000000
0.04
University Medical Center Schleswig-Holstein - Campus Lübeck (UKSH Lübeck), Germany
0.500000
0.02
Institut du Thorax (IdT), France
0.500000
0.02
University of Nantes, France
0.500000
0.02
Boston University (BU), United States of America (USA)
0.500000
0.02
VA Puget Sound Health Care System (VAPSHCS), United States of America (USA)
0.500000
0.02
UW Medicine, United States of America (USA)
0.500000
0.02
King's College London (KCL), United Kingdom (UK)
0.333333
0.01
Foundation for Liver Research, United Kingdom (UK)
0.333333
0.01
King's College Hospital, King's College Hospital NHS Foundation Trust, United Kingdom (UK)
0.333333
0.01